[Administration of solcoseryl in the complex treatment and intrahospital rehabilitation of patients with myocardial infarction].
Clinical efficacy of solcoseryl was studied in 58 patients with acute myocardial infarction. Forty patients receiving no solcoseryl were included into a control group. The agent contributed to a reduction in the frequency of anginal episodes, a more rapid improvement of circulatory failure signs, and an increase in exercise tolerance.